Home  >  About MEDICAL FAIR ASIA 2014


The No. 1 Medical and Healthcare trade fair in the region
Returns For Its 10th Edition


As Asia's leading and most established trade fair focused on equipment and supplies for the hospital, diagnostic, pharmaceutical, medical and rehabilitation sectors, MEDICAL FAIR ASIA 2014 serves as an ideal international platform for some of the industry's best suppliers to showcase latest developments and product innovations in their field.

Since the trade fair debuted in 1997 (under the name HOSPIMedica), MEDICAL FAIR ASIA has established its reputation with both local and international medical professionals as Asia's most definitive medical and health care exhibition. In tandem, the trade fair has also received growing support and official endorsement from the industry that include the Ministry of Health, Singapore, and a wide range of regional medical and health care associations.

Modelled after the sector's No. 1 global medical trade fair - MEDICA, organized by Messe Duesseldorf in Germany, the 10th edition of MEDICAL FAIR ASIA 2014 will take place from 9 to 11 September 2014 at Suntec Singapore.

MEDICAL FAIR ASIA 2014 will bring together a multitude of new and innovative technologies, solutions, products and services - many of which will be launched in Asia for the first time - but will also align its theme with current and future demographic trends, challenges and policies, and notably - the next wave of healthcare modernization. MEDICAL FAIR ASIA 2014  comes at a time when Singapore expects to increase its healthcare spend by 6% annually to reach US$12.6 billion by 2015 - making Singapore an ideal location for specialised trade fairs like MEDICAL FAIR ASIA.

Asia at a glance

Asia's share of those aged 65 and above in the world population exceeded 50% in 2000, and is projected to grow to 61% by 2050. Ageing in Asian markets will therefore drive increased demand for quality healthcare products and services.

More significantly, changes in public policy, push for healthcare reform and the influx of government investment in healthcare infrastructure have been growing priorities among economies in Asia. Take for example countries like Malaysia and Vietnam which are working towards consolidation of services through the upgrading of facilities and equipment, and healthcare spending in Vietnam which is projected to rise to US$6 billion by 2014, with the government accounting for around 30% of total expenditure.

Eyes on Southeast Asia

The future for the medical industry in Asia looks positive with the stimuli for industry growth geared mainly towards greater investment in private sector delivery, public-private partnerships, and investments in the medical devices industry. According to consultancy Frost & Sullivan, by 2015, Asia Pacific's healthcare market is expected to reach close to 33% of the global healthcare market and estimated to be valued at about US$521 billion, with trends in the medical device industry in Asia mainly centred on imaging, cardiovascular, and healthcare IT. A key driver for the Southeast Asian region is the impending liberalisation of the services sector by 2015 under the ASEAN agreement.

Rise in private healthcare spending

With a rapidly changing landscape of rising wealth and private sector innovation, private healthcare is increasingly within the reach of a greater number of people.

A 2012 study produced by the Deloitte Centre for Health Solutions indicates that Southeast Asia has the highest private health expenditure of any region in the world, at 63.1% of total health expenditures. This is largely due to the growing realisation that the private sector can yield greater efficiency, as evident by the increased frequency of public-private collaboration. Providers such as Parkway, Fortis and the Bangkok General Group for example have over the last few years built up considerable expertise in Singapore, Malaysia and Thailand.

The growing phenomenon of medical tourism particularly in Singapore and Thailand has also accelerated private health expenditure. With growing recognition by many governments and private healthcare providers that to address the needs of the population, as a government and to achieve sustained growth, as a business - well-structured healthcare public-private partnerships have a prominent role to play.

Singapore plays a leading role in the region

According to Frost & Sullivan, Singapore will increase its healthcare spend to reach US$12.6 billion in 2015. The steady rise in healthcare expenditure is due to Singapore's ageing demographic as the country is expected to be the fourth ''oldest'' country in the world by 2050, with the average age exceeding 60 years old. There will also be more hospital beds in Singapore, which will also serve to fuel healthcare demand with projections estimated to reach 12,868 hospital beds by 2015. Three-quarters of the beds, or 9,687, will come from the public sector and the rest from the private sector.

Singapore's healthcare sector is also striving to achieve an entirely paperless system and will fully complete the transition to electronic medical records (EMR) by the end of 2013, ahead of South Korea and Taiwan who embarked on the project earlier. Currently, Singapore has a fully-integrated EMR between hospitals and polyclinics, with the system soon to include general practitioners.

In an article published by The Business Times (10 August, 2012) on Singapore's healthcare spending, it indicated that the way health care is provided in Singapore and the region will also begin to change. For starters, treatment and services will move from hospitals to homes to better serve the greying population in countries such as Singapore, South Korea and Japan. And as more patents for drugs that address chronic diseases such as diabetes and hypertension expire, healthcare retailers may also start to produce and sell generic versions.

Eleven years into Singapore's biomedical sciences (BMS) push, the sector has also grown into a sizeable stable of almost 300 companies and businesses including over 30 global medical technology companies that have set-up commercial-scale manufacturing plants in Singapore.

Singapore - Asia's Medical Hub

  • Growing biomedical manufacturing industry
  • Thriving pharmaceutical industry
  • To date, thirteen hospitals and medical centres in Singapore have obtained Joint Commission International (JCI) accreditation
  • Among the top 5 Medical Travel Health Care Destinations in Asia
  • Ranked 2nd in terms of its health & environment competitive landscape (IMD World Competitiveness Yearbook 2010)
  • World's 4th best healthcare infrastructure (World Competitiveness Yearbook 2010, IMD)

Product Range
See the product range showcased at MEDICAL FAIR 2014

Visitor Target Group
View  MEDICAL FAIR ASIA 2014 visitors target group by industry and job function

Review 2012
Discover the latest medical technology solutions at the exhibition

Copyright © 2013. All rights reserved. Messe Düsseldorf Asia  |  Privacy Statement